提高D-二次数条:对年龄调整的D-二次数值进行叙事性审查
Tayssir Fatah1, Judith Catella2,3, Christophe Nougier1,4
1Service d'Hématologie Biologique et d'Hémostase clinique, Hospices Civils de Lyon, Bron, France.
Research and practice in thrombosis and haemostasis
|January 9, 2026
概括
根据年龄调整的D-二分体值通过增加特异性来改善老年人静脉血栓栓塞 (VTE) 诊断. 虽然对效率和成本效益有希望,但为了广泛的临床使用,需要进一步验证.
科学领域:
- 临床诊断 临床诊断 临床诊断
- 血液学 血液学 血液学
- 医学成像医学成像
背景情况:
- 在排除静脉血栓栓塞 (VTE) 方面,D-二聚体检测至关重要.
- 老年患者的D-二聚物水平升高会使静脉瘤诊断复杂化.
- 建议对50岁以上的患者进行年龄调整的门值 (年龄×10μg/L).
研究的目的:
- 审查年龄调整的D-二次数值的建立,效率和安全性.
- 专注于HemosIL D-dimer测定及其在VTE诊断中的作用.
- 评估年龄调整值在优化VTE管理中的有用性.
主要方法:
- 现有关于年龄调整的D-二次元值研究的叙述性综述.
- 在疑似肺栓塞的情况下,在急诊室设置中对D-二次体解释的分析.
- 检查有关深静脉血栓 (DVT) 诊断和年龄调整值的数据.
主要成果:
- 根据年龄调整的门提高了特异性,而不会牺牲怀疑肺栓塞的患者中排斥VTE的敏感性.
- 这种方法可以减少对成像的依赖,降低医疗保健成本.
- 新出现的证据表明,DVT排除常规方法的安全性和效率相当,但缺乏大型前性试验.
结论:
- 根据年龄调整的D-分位数值为成本有效的VTE管理提供了一个有希望的策略,特别是在老年人群中.
- 需要进行进一步的研究和大规模的前性试验,以验证其在不同患者群体和D-二次体测定中有效性和安全性.
- 在常规临床整合年龄调整的D-二次数值之前,测试特定的验证至关重要.
相关概念视频
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
284
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
284
Venous Thrombosis III: Interprofessional Care
276
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
276
Pharmacodynamics in Geriatric Patients: Effects of Age
183
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
183
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
308
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
308

